Researchers urge use of two drugs to prevent HIV transmission

08/4/2008 | Financial Times (free content)

Leading AIDS researchers, backed by the the AIDS Vaccine Advocacy Coalition, called for increased funding to study widespread use of Gilead Sciences' HIV drugs tenofovir and emtricitabine as preventive therapy for those at high risk of the disease. The recommendation came after several setbacks in recent studies aimed at discovering vaccines against HIV infection.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA